1. Home
  2. MTEX vs LEXX Comparison

MTEX vs LEXX Comparison

Compare MTEX & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEX
  • LEXX
  • Stock Information
  • Founded
  • MTEX 1993
  • LEXX 2004
  • Country
  • MTEX United States
  • LEXX Canada
  • Employees
  • MTEX N/A
  • LEXX N/A
  • Industry
  • MTEX Medicinal Chemicals and Botanical Products
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTEX Health Care
  • LEXX Health Care
  • Exchange
  • MTEX Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • MTEX 15.8M
  • LEXX 16.5M
  • IPO Year
  • MTEX 1999
  • LEXX N/A
  • Fundamental
  • Price
  • MTEX $7.80
  • LEXX $1.19
  • Analyst Decision
  • MTEX
  • LEXX Strong Buy
  • Analyst Count
  • MTEX 0
  • LEXX 1
  • Target Price
  • MTEX N/A
  • LEXX $4.00
  • AVG Volume (30 Days)
  • MTEX 10.4K
  • LEXX 188.7K
  • Earning Date
  • MTEX 11-11-2025
  • LEXX 07-14-2025
  • Dividend Yield
  • MTEX N/A
  • LEXX N/A
  • EPS Growth
  • MTEX N/A
  • LEXX N/A
  • EPS
  • MTEX N/A
  • LEXX N/A
  • Revenue
  • MTEX $112,975,000.00
  • LEXX $615,923.00
  • Revenue This Year
  • MTEX N/A
  • LEXX $46.98
  • Revenue Next Year
  • MTEX N/A
  • LEXX $17.26
  • P/E Ratio
  • MTEX N/A
  • LEXX N/A
  • Revenue Growth
  • MTEX N/A
  • LEXX 49.85
  • 52 Week Low
  • MTEX $7.05
  • LEXX $0.77
  • 52 Week High
  • MTEX $16.49
  • LEXX $3.72
  • Technical
  • Relative Strength Index (RSI)
  • MTEX 41.05
  • LEXX 71.37
  • Support Level
  • MTEX $8.21
  • LEXX $0.98
  • Resistance Level
  • MTEX $9.80
  • LEXX $1.07
  • Average True Range (ATR)
  • MTEX 0.74
  • LEXX 0.10
  • MACD
  • MTEX -0.14
  • LEXX 0.03
  • Stochastic Oscillator
  • MTEX 0.00
  • LEXX 72.01

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: